Atea Pharmaceuticals, Inc.
SEC CIK 1593899 · AVIR · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Berger Franklin M | Director | filed 2020 - 2026 |
| Kirsch Arthur S | Director | filed 2025 - 2026 |
| Duncan Barbara Gayle | Director | filed 2020 - 2026 |
| Polsky Bruce | Director | filed 2020 - 2026 |
| Murphy Polly A. | Director | filed 2020 - 2026 |
| Lucidi Bruno | Director | filed 2020 - 2026 |
| Adams Jerome M. | Director | filed 2021 - 2026 |
| Berman Howard | Director | filed 2025 - 2026 |
| Sommadossi Jean-Pierre | Director · President, CEO, and Chairman | filed 2020 - 2026 |
| Chen Bihua | Director | filed 2020 - 2020 |
| Hack Andrew A. F. | Director | filed 2020 - 2020 |
| Cheng Isaac | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Corcoran Andrea | See Remarks | filed 2020 - 2026 |
| Foster Wayne | See Remarks | filed 2020 - 2026 |
| Horga Maria Arantxa | Chief Medical Officer | filed 2020 - 2026 |
| Vavricka John | Chief Commercial Officer | filed 2020 - 2026 |
| Hammond Janet MJ | Chief Development Officer | filed 2020 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.